Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoscale Device Developed for Separation of NA Mixtures

By LabMedica International staff writers
Posted on 24 Mar 2017
A team of Japanese engineers has developed a nanoscale device for the rapid separation of microRNA (miRNA) from mixtures of miRNA, RNA, and DNA.

MicroRNAs are a small noncoding family of 19- to 25-nucleotide RNAs that regulate gene expression by targeting messenger RNAs (mRNAs) in a sequence specific manner, inducing translational repression or mRNA degradation, depending on the degree of complementarity between miRNAs and their targets. More...
Many miRNAs are conserved in sequence between distantly related organisms, suggesting that these molecules participate in essential processes. In fact, miRNAs have been shown to be involved in the regulation of gene expression during development, cell proliferation, apoptosis, glucose metabolism, stress resistance, and cancer.

Investigators at Nagoya University have developed an innovative nanoscale device that can rapidly separate microRNA from DNA/RNA mixtures obtained from cells.

The device was fabricated by electron beam lithography on a quartz substrate to contain a 25×100 micrometer array of "nanopillars" (small columns with a diameter of 250 nanometers and height of 100 nanometers) in shallow "nanoslits" with a height of 100 nanometers. This separation approach using a top-down fabrication technique enabled the precise control of DNA conformation during electrophoresis and demonstrated that the geometric pattern of the nanopillar array could control the separation mode and enhance the throughput. The square pattern improved the resolution of separation proportionally to the applied electric field and transferred the larger DNA molecules more rapidly than it transferred the smaller molecules of miRNA. Combining nanoslit structures provided an entropic trapping effect and improved the speed of separation and resolution.

Feasibility studies, using a mixture of total RNA and genomic DNA, were performed to elucidate whether this technique was applicable over a wide size range of nucleic acids. Results published in the March 8, 2017, online edition of the journal Scientific Reports revealed that a mixture of genomic DNA, total RNA, and miRNA from HeLa cells could be separated within 100 microseconds.

"We believe that the nanobiodevice separates microRNA from mixtures through a combination of two different physical behaviors of confined polymers in the nanopoillar array, non-equilibrium transport and entropic trapping," said contributing author Dr. Noritada Kaji, associate professor of engineering at Nagoya University. "The applied electric field combines with the unique nanostructure of the nanobiodevice to generate a strong electric force that induces rapid concentration and separation."


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
New
Clinical Chemistry System
P780
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.